Rl. Trestman et al., THE STABILITY OF PLASMA GROWTH-HORMONE AND MHPG RESPONSES TO REPEATEDCLONIDINE CHALLENGE IN NORMAL MALES, Psychoneuroendocrinology, 19(1), 1994, pp. 13-20
Clonidine is a centrally acting alpha2-adrenergic agonist used in many
psychiatric studies to assess adrenergic functioning. The short- and
long-term stability of plasma growth hormone (GH) and plasma 3-methoxy
-4-hydroxy phenylglycol (MHPG) responses to clonidine (2 mug/kg IV) ov
er a 60-min period were assessed in subsets of 13 male normal controls
on 2 consecutive days (Study A; n = 11) and on 2 days separated by se
veral months (Study B; n = 11). In Study A, no significant differences
between consecutive days were found in either baseline plasma GH or M
HPG or their responses to clonidine. The 60 minute plasma GH responses
between consecutive days were highly correlated (r = 0.75, n = 11, p
< .001), while the 60 min plasma MHPG responses were not. In Study B.
no significant differences in baseline plasma GH or MHPG, or their res
ponses to clonidine challenge, were found between the 2 test days. How
ever, neither the plasma GH responses nor the plasma MHPG responses to
clonidine at 60 min correlated significantly between the 2 study days
separated by several months. Both in Study A and in Study B, 8 of 11
subjects had a stable GH response to clonidine across both study days
when defined dichotomously (blunted < 4 ng/ml; otherwise, not blunted)
. These results suggest that the plasma GH response and plasma MHPG re
sponse to clonidine are unaffected by repeat clonidine challenge separ
ated by 24 h, and that the plasma GH response to clonidine may be more
stable over time than the plasma MHPG response to clonidine.